Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
MediumPositive
Announced Thu, 25 Jun · 10:09 IST

Bumper debut! Avience Biomedicals share price lists at 90% premium over the IPO price

View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Avience Biomedicals made a strong stock market debut on 25 June, listing at a 90% premium over its IPO price of ₹208. The shares opened at ₹395.20 apiece on NSE SME, delivering significant gains to IPO allottees on day one.